News & Updates

Show Multimedia Only
Oral misoprostol solution measures up to tablet formulation for labour induction

Oral misoprostol solution measures up to tablet formulation for labour induction

08 Nov 2024
Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication

Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication

08 Nov 2024

Vonoprazan-based bismuth-containing quadruple therapy (VBCQ) does better at eradicating Helicobacter pylori (H. pylori) than proton pump inhibitor (PPI)-based BCQ therapy (PBCQ), with similar adverse reactions and compliance, a study has shown.

Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication

08 Nov 2024
Disabling foot pain in PsA: Marker of worse PsA, significant burden on daily life

Disabling foot pain in PsA: Marker of worse PsA, significant burden on daily life

07 Nov 2024 byJairia Dela Cruz

For Singaporeans with psoriatic arthritis (PsA), disabling foot pain appears to signal a more severe disease activity and exert a wide impact on daily life.

Disabling foot pain in PsA: Marker of worse PsA, significant burden on daily life

07 Nov 2024